| Study | Pathogen | Clinical evidence review comparison |
|---|---|---|
| Cohorts by pathogen | ||
| Federiksen 1999 | Chronic PA & Intermittent PA | Comparison 6. Cohort segregation versus no cohort segregation (inpatient and outpatient) |
| France 2008a | Intermittent BCC | Comparison 6. Cohort segregation versus no cohort segregation (inpatient and outpatient) |
| Hoiby 1989b | Chronic PA | Comparison 6. Cohort segregation versus no cohort segregation (inpatient and outpatient) |
| Lee 2004 | Chronic PA & Intermittent PA | Comparison 2. Cohort segregation by location versus no cohort segregation (outpatient) |
| Whitford 1995 | Intermittent BCC | Comparison 6. Cohort segregation versus no cohort segregation (inpatient and outpatient) |
| Protective equipment | ||
| Chen 2001a | Intermittent BCC | Comparison 10. Cohort segregation + individual segregation + protective equipment versus usual care (inpatient and outpatient) |
| Savant 2014 | Intermittent PA | Comparison 3. Combination of protective equipment + individual segregation versus incomplete protective equipment + incomplete individual segregatione (outpatient) |
| Single inpatient room versus ward bed | ||
| Chen 2001a | Intermittent BCC | Comparison 9. Cohort segregation + individual segregation versus cohort segregation (inpatient and outpatient) |
| France 2008a | Intermittent BCC | Comparison 7. Complete cohort segregation versus incomplete cohort segregation (inpatient and outpatient) |
| Incomplete cohort segregation including en suite bathroom facilities versus no cohort segregation | ||
| Jones 2005 | Superinfection with chronic PAc & Intermittent PAd | Comparison 6. Cohort segregation versus no cohort segregation (inpatient and outpatient) |
BCC, B cepacia complex; PA, P aeruginosa
Intermittent assumed as chronic not reported
Multiply resistant pseudomonas assumed to have a similar treatment cost and effect on quality of life as chronic pseudomonas
Incidence of superinfection by transmissible strains among people with cystic fibrosis already infected with chronic P aeruginosa
New cases of P aeruginosa infection with transmissible strain among people with cystic fibrosis without chronic P aeruginosa infection assumed to have a similar treatment cost and effect on quality of life as intermittent P aeruginosa
Individual segregation achieved through a “no-waiting” room policy incurring no additional cost to incomplete segregation
From: Appendix K, Health Economics
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.